This draft Commission Implementing Decision repeals the latest postponement of the expiry date of the approval of aluminium phosphide releasing phosphine as an active substance for use in biocidal products of product-types (PT) 14, 18 and 20. On 26 February 2020, applications was submitted in accordance with Article 13(1) of the Regulation (EU) No 528/2012 of the European Parliament and of the Council (BPR) for the renewal of the approval of aluminium phosphide releasing phosphine for PT 14, 18 and 20. Commission Implementing Decision (EU) 2021/1284 postponed the expiry date of the approval of aluminium phosphide releasing phosphine for PT 14 and 18 to 31 July 2024. Commission Implementing Decision (EU) 2024/732 postponed further the expiry date of the approval of the substance for PT 14 and 18 to 31 January 2026. Finally, that expiry date was again extended to 31 July 2027 by Commission Implementing Decision (EU) 2025/2279. In parallel, Commission Implementing Decision (EU) 2025/461 postponed the expiry date of the approval of aluminium phosphide releasing phosphine for PT 20 to 31 January 2026. That expiry date was again extended to 31 July 2027 by Commission Implementing Decision (EU) 2025/2279. On 27 May 2026 the Agency adopted its opinions on aluminium phosphide releasing phosphine for PT 14, 18 and 20, having regard to the conclusions of the evaluating competent authority. Given the opinions of the Agency, it is appropriate to renew the approval of aluminium phosphide…